Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma
Conditions
Hepatocellular Carcinoma · Advanced Hepatocellular Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Changhua Christian Hospital (CCH), Changhua, Taiwan
Ditmanson Medical Foundation Chiayi Christian Hospital (CYCH), Chiayi City, Taiwan
Chang Gung Medical Foundation-Chia-Yi (CGMF-CY), Chiayi City, Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH), Kaohsiung City, Taiwan
Chang Gung Medical Foundation-Kaohsiung(CGMF-KS), Kaohsiung City, Taiwan
Chi Mei Medical Center (CMMC-YK), Tainan, Taiwan
Chi Mei Hospital, Liouying (CMMC-LY), Tainan, Taiwan
Chang Gung Medical Foundation-Linkou (CGMF-LK), Taoyuan, Taiwan
Bach Mai Hospital, Hanoi, Vietnam
K Hospital, Hà Nội, Vietnam
Hue Central Hospital, Huế, Vietnam
Study leads
John S Bomalaski
Study Director
Polaris Group